Recent BEAT News
- HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time • Business Wire • 04/25/2024 12:31:00 PM
- HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias • Business Wire • 04/09/2024 12:31:00 PM
- HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 03/20/2024 08:05:00 PM
- First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG • Business Wire • 03/14/2024 12:31:00 PM
- HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology • Business Wire • 03/07/2024 01:31:00 PM
- HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time • Business Wire • 03/05/2024 01:31:00 PM
- HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights • Business Wire • 12/14/2023 01:31:00 PM
- HeartBeam Reports Third Quarter 2023 Financial Results • Business Wire • 11/14/2023 09:01:00 PM
- HeartBeam Announces Expansion of Its Scientific Advisory Board • Business Wire • 11/09/2023 01:31:00 PM
- HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias • Business Wire • 11/07/2023 01:31:00 PM
- HeartBeam to Host Third Quarter 2023 Results Conference Call on Tuesday November 14, 2023 at 4:30 p.m. Eastern Time • Business Wire • 10/31/2023 12:31:00 PM
- Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer • PR Newswire (US) • 09/27/2023 12:05:00 PM
- HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team • Business Wire • 09/26/2023 12:31:00 PM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- HeartBeam Reports Second Quarter 2023 Financial Results • Business Wire • 08/10/2023 08:01:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:00:36 PM
- HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks • Business Wire • 08/09/2023 12:31:00 PM
- HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs • Business Wire • 08/08/2023 12:31:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2023 01:43:51 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2023 01:41:10 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2023 10:39:25 PM
- HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time • Business Wire • 07/27/2023 12:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2023 12:35:33 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM